行情

ADMP

ADMP

Adamis制药
NASDAQ

实时行情|Nasdaq Last Sale

1.180
-0.050
-4.07%
盘前: 1.250 +0.07 +5.93% 04:48 08/10 EDT
开盘
1.210
昨收
1.230
最高
1.280
最低
1.150
成交量
539.23万
成交额
--
52周最高
1.510
52周最低
0.2700
市值
8,722.65万
市盈率(TTM)
-2.2118
分时
5日
1月
3月
1年
5年

分析师评级

3位分析师的综合评级

中性

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

目标价格预测

分析师预测ADMP价格均价为1.000,最高价位1.000,最低价为1.000。

EPS

ADMP 新闻

更多
Adamis Pharmaceuticals (ADMP) May Report Negative Earnings: Know the Trend Ahead of Q2 Release
Adamis (ADMP) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Zacks · 3天前
Adamis Pharmaceuticals Regains Compliance with NASDAQ Minimum Bid Price Requirement
SAN DIEGO, Aug. 05, 2020 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (NASDAQ: ADMP) announced today that it has received a letter from the NASDAQ Listing Qualifications Staff (“Nasdaq”) notifying the company that as a result of the closing bid price
GlobeNewswire · 4天前
Healthcare - Top 5 Gainers / Losers
Seeking Alpha · 07/30 15:04
LYG, BBVA among premarket losers
Seeking Alpha · 07/30 12:13
The Daily Biotech Pulse: Bristol-Myers, Bluebird Bio Resubmit Multiple Myeloma Drug BLA, FSD To Close Medicinal Cannabis Business, Hologic's Blowout Quarter
Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 29)
Benzinga · 07/30 12:09
LB, ADMP, APHA and NMM among midday movers
Seeking Alpha · 07/29 16:42
Sonoma Pharmaceuticals leads healthcare gainers; Aphria and Soligenix among losers
Seeking Alpha · 07/29 15:00
FDA mandates new opioid labeling aimed at building awareness of naloxone
The FDA is now requiring labeling for opioid pain meds and therapies to treat opioid use disorder recommending that healthcare professionals discuss the av
seekingalpha · 07/24 00:25

所属板块

制药
+0.19%
制药与医学研究
+0.08%

热门股票

代码
价格
涨跌幅

ADMP 简况

Adamis Pharmaceuticals Corporation是一家制药公司。该公司从事特种药品的开发业务。该公司正在为过敏与呼吸市场开发多种产品,包括从3M Company(3M)收购的干粉吸入器技术。该公司的产品包括特种药品(如肾上腺素预充式注射器(PFS)、APC-5000干粉吸入器(DPI)、APC-1000和APC-2000)以及生物技术产品(如TeloB-VAX(疫苗)、APC-100、APC-200和APC-300)。该公司的先导候选产品肾上腺素注射液美国药典(USP) 1:1000 0.3毫克预填充单剂量注射器或肾上腺素PFS是一种治疗过敏反应的预充式注射器,旨在提供预测量的0.3毫克剂量的肾上腺素。该公司还拥有被称为体细胞转基因免疫(STI)技术的授权疫苗技术。
展开

微牛提供Adamis Pharmaceuticals Corp(NASDAQ-ADMP)的股票价格,实时市场报价,专业分析师评级,深度图表和免费的ADMP股票新闻,以帮助您做出投资决策。

模拟交易:模拟炒股免费实操交易技能。您可用虚拟资金在真实市场环境中零成本、零风险体验交易ADMP股票基本功能。